Beyond the review: additional non-oncologic drugs with clinically significant cardiovascular effects

Authors

Institutions

Publication Details

Journal
European Heart Journal - Cardiovascular Pharmacotherapy
Published
2026-04-22
DOI
https://doi.org/10.1093/ehjcvp/pvag029
Primary Topic
Chemotherapy-induced cardiotoxicity and mitigation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Beyond the review: additional non-oncologic drugs with clinically significant cardiovascular effects

Thomas Vanassche, L Van der Linden
European Heart Journal - Cardiovascular Pharmacotherapy
Chemotherapy-induced cardiotoxicity and mitigation
article

Beyond the review: additional non-oncologic drugs with clinically significant cardiovascular effects

Thomas Vanassche, L Van der Linden
article en

Abstract

No abstract available for this paper.
European Heart Journal - Cardiovascular Pharmacotherapy
KU Leuven (BE)
Good health and well-being
Openalex Percentile: Top 17%
Chemotherapy-induced cardiotoxicity and mitigation
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.